29/12/2016 - 22:06

MGC Pharma successfully harvests trial medicinal cannabis crop in Slovenia

29/12/2016 - 22:06

Bookmark

Upgrade your subscription to use this feature.

ASX-listed MGC Pharmaceuticals says it is on schedule to commence production of research grade cannabis by mid-2017 after harvesting its first crop at its Slovenian facilities. In a strong finish to 2016, the company has also confirmed the execution of its deal to acquire Czech-based medical cannabis company Panax Pharma on more favourable terms.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options